Denali Therapeutics (4DN.F) Q2 2026 Earnings

May 7Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.69
-0.65
-0.62
-0.59

Details

Expected EPS
-0.61676264377
Actual EPS
-0.5883423
Surprise EPS
0.03
Surprise Percent
+4.61%

Description

⁨Denali Therapeutics⁩ (⁦4DN.F⁩) has reported earnings of ⁦-0.5883423⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts